Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CVSI virtually attending the Cowen Boston Cannabis Conference taking place on November 30 – December 2, 2020. Maybe Joe caused some increased volume?
https://www.meetmax.com/sched/event_63949/__co-list_cp.html
This shows all foreign application status. Click on JP View dossier.
https://globaldossier.uspto.gov/#/result/application/US/15426617/489009
Those are old facts. Straight from the USPTO Global dossier. You can see a lot happened after June 18 publication and pending status you posted.
Decision to Grant a Patent (ORIGINAL) 11/24/2020 A01-JP unknown
Decision to Grant a Patent (TRANSLATED) 11/24/2020 A01 23,2,101,102
Written Opinion (ORIGINAL) 09/11/2020 A53-JP unknown
Written Opinion (TRANSLATED) 09/11/2020 A53 4
Written Amendment (ORIGINAL) 09/11/2020 A523-JP unknown
Written Amendment (TRANSLATED) 09/11/2020 A523 4
Notice of Reasons for Refusal (ORIGINAL) 06/30/2020 A131-JP unknown
Notice of Reasons for Refusal (TRANSLATED) 06/30/20
Coincidentally the Japanese patent will be granted.
What was posted on the yahoo board in 2019 was not a patent but
what was just posted in the public pair global dossier for Japan November 24 2020 will be a patent. I expect a formal announcement in six weeks.
(just like the US patent we knew about before formal assignment.)
(it actually says sea bouy a science,ink)(hope that gets corrected)
Decision to Grant a Patent
Application number: Japanese Patent Application No. 2018-558730
Date of Drafting: Reiwa 2(2020) November 16
Patent examiner: FUKUYAMA, Noriaki 1581 4C00
Title of the invention:Pharmaceutical formulations comprising cannabidiol and
nicotine in a smokeless tobacco addiction treatment.
The number of claims: 19
Applicant: Sea buoy A science, ink.
Representative: Patent business corporation Shin-Ei Patent Firm
This application is to be granted a patent, since no reason for refusal has been
found.
A new white label in Japan using cvsi product.
We wish them well.
https://sumiki.tokyo/
Just to add fuel to your fire on cellular agriculture I posted this back in April.
Post #
65888
of 70234
In light of the new patent allowance the meeting with the FDA back in January takes on a new meaning. At the time I thought CVSI seemed the odd man out of this coalition. All the other companies are providers of Pharmaceutical grade cannabinoids. CVSI used the cbd from Noramco in the
recent study and affidavit submitted to the patent office that helped turn the patent approval around. Noramco is part of Purisys. Two of the other companies are making cannabinoids thru CELLULAR AGRICULTURE. Just trying to figure out if there is a common denominator why cvsi is in this coalition.
Event Date: 01/16/2020
Location: Silver Spring, MD
Subject: Listening Session with the Cannabidiol (CBD) Coalition
FDA Participant/Group: ALISON THOMPSON; JOSEPH FRANKLIN; RACHEL OSTERMAN; CARA WELCH; LOWELL SCHILLER; SHARON MAYL; MICHAEL LEVY; MELISSA ROBB; CASSANDRA TAYLOR; DENNIS KEEFE; APRIL ALEXANDROW; STEVEN TAVE; REBECCA GOLDBERG; SHERENE SEPEHRI;
Non FDA Participant/Group: Brendan Carroll, Marc Scheineson (Alston & Bird LLP); Cynthia Bryant (Demetrix, Inc.); Bill Grubb (Noramco); Angelo Fefekos, Etan Bendheim, Jeremy Friedberg (LAVVAN, Inc.); Wendi Young (Mile High Labs); Josh Hoerner, Scott Warner (Purisys); Douglas “Duffy” McKay, Joseph Dowling (CV Sciences, Inc.); Trevor Peters (Willow Biosciences)
Today is day 45 since the CVSI PR of October 6th when they stated "the launch of 30+ new PlusCBD™ products over the next 45 days"
I only count about 15. If my count is close we hopefully have some announcements next week.
I know, I know. Just feels different now.
Watch and learn.
Efficiency is comparable to present medications
"we're very excited about that" Minute 12
https://vimeo.com/371510595
Investors should be anticipating a cvsi IND submission to FDA. Everything seems to be in place.
What we know.
From 5/1/2018 to 4/31/2019 Olivier George from UCSD was the PI for CV Sciences study titled "effects of CBD on nicotine".
The goal was "to perform IND Enabling studies for medication development"
You can see this on page 8 #9 here.
https://www.oliviergeorge.com/cv
So what exactly are IND enabling studies?
"IND-enabling studies are conducted to evaluate potential toxicity risks prior to human studies and to estimate starting doses for clinical trials. Key IND-enabling studies include pharmacology, pharmacokinetics, and toxicology assessments"
Which leads us to the comments CEO Dowling made in the Q3 call transcripts.
"We have completed the pharmacological and toxicological studies in support of planned clinical studies"
https://seekingalpha.com/article/4385685-cv-sciences-incs-cvsi-ceo-joe-dowling-on-q3-2020-results-earnings-call-transcript
Only thing left to do is submission to FDA for their approval to proceed. They usually approve within 30 days. Hoping before the end of year. Any sign that CVSI 007 is proceeding should draw new investors with deep pockets.
A nicely done brand book from 2 months ago shows pet products?https://issuu.com/cvsciences/docs/cv_brand_book_7x7_091620_1_
Nice write up in convince store news.
https://www.cspdailynews.com/cbdhemp/how-convenience-channel-will-help-cbd-grow
Is this new? A CV Defense collaboration with Gencor,
https://www.nutritioninsight.com/news/gencor-and-cv-sciences-team-up-on-cbd-alternative-for-immunity.html
I believe the 30+ new products will dispel the notion that cvsi has been too conservative in their approach to products and cbd mg serving size.
There are photos of the +PROCBD that will contain 100mg per serving.
Also believe they will reintroduce vaping liquids. We'll see?
Trying to make sense of why cv science defense would be mentioned in the html formatting? of the ingredients of this product. https://www.walmart.com/ip/LuckyVitamin-Immune-Balance-with-Epicor-60-Veg-Capsules/429706075
Just listed in Convenience Store News. New product Happy Lane.
https://csnews.com/
https://csnews.com/happy-lane-cbd-product-line
Is anyone Tik Tok savvy? Forwarded to cvsi after reading Forbes story but maybe someone here could post one of our videos on Tik Tok? Maybe the one about making your circle larger or the 30 second Happy Lane video?
https://www.forbes.com/sites/lindseybartlett/2020/09/22/tiktok-is-a-valuable-tool-for-cbd-companies-heres-why/#6363c3695409
CVSI Lex Pelger will give two seminars during the virtual cosmetics event. Hopefully the cvsi cosmetic brand Potentia is imminent.
https://www.beautyaccelerate.com/BA/public/MainHall.aspx?ID=3303&sortMenu=101000
Harnessing the Endocannabinoid System for 'Wellness Cosmetics': CBD 2.0
8:00 AM – 8:50 AM CST Session Sponsor: Introduction by Biocogent
Speaker(s): Lex Pelger
Learn about the role of the endocannabinoid system in the skin, what's known of CBD's effects and other endo- and phyto-cannabinoids that may be used in the future. Product developers will be inspired with novel chemistries & pathways to craft wellness cosmetic experiences. Marketers will gain exposure to alternate realities for new iterations of this booming sector.
Cannabinoids in Cosmetics
Speaker(s): Lex Pelger
CBD is only the beginning for the cosmetics market. Endocannabinoids and their related receptors can impart a sense of relaxation and anti-stress effects in users, perfectly aligning with the self-care and wellness movement. Join the discussion to gain insights on the next steps in this market space.
A lot of info in this Brightfield report.
We have .8% of the market.
0.3% of companies were in the top tier (with annual sales of $40+ million)
• 0.7% of companies were in the mid-high tier (with annual sales of $10-40 million)
• 1.3% of companies were in the mid-tier (with annual sales of $1-10 million)
• 97.7% of companies were in the low tier (with annual sales of <$1 million)
https://hempindustrydaily.com/wp-content/uploads/2020/08/US-CBD-Market-Report_V2-1.pdf
CV ACUTE in stock beginning to show up online $34.99
https://www.lhasaoms.com/what-s-new/cv-acute-immune-support
https://www.naturalpartners.com/us/cv-acute-immune-support/CVS001PAR
A optimistic tweet from a organization thats been reluctant to be.
US Hemp Roundtable
@HempRoundtable
·
19h
Hemp Supporters: We are anticipating some big news for #hemp and #CBD over the next couple of weeks
Sounds like the options have been put on hold until a judicial determination is made.
"Having voided and rescinded the Employment Agreement CV Sciences has terminated its performance under the Employment Agreement and has ceased to
compensate Mona Jr. under it."
Found the COA for CV ACUTE. Looks like they may have gone the extra mile to accommodate the Amazons of the world. Four different Labs are listed.
Alkemist labs,Auresco Labs, Eurofins and CV Sciences. Its a 13 page COA
https://cvsciences.com/wp-content/uploads/2020/08/CV-Acute-COA.pdf
ANIA, link to fda solicitation.
https://beta.sam.gov/opp/7990bed5f9aa450c9e279ea37de3e1aa/view
New website is up for +HEMP OIL.This branding may be for stores that
won't allow CBD on the label. I know a local store here in San Diego pulled
pluscbd for that reason.
https://www.thisishealthtransformed.com/
The way i read it is that he is on the advisory board or a DSMB for one of the
three companies. Just speculating but it seems CVSI is being accommodating
to someone in Europe
Beginning to speculate that CVSI may already have a partner to develop 007 based on contingencies. Mr dowling has stated many times that clinical trials would probably be conducted in Europe. Now it seems we have a Frenchman that may be in charge of the development. Henri-Jean Aubin in a recently published study under the competing interest ethics statement said that he was a advisor for CV Sciences.
Mr Aubin seems to be a leading figure in addictions and nicotine cessation.
He has also advised many pharmaceuticals over the years.
"Dr. Aubin reported being a member of advisory boards or DSMB for Bioprojet, CV Sciences, and Ethypharm"
The "white paper" was presented to the OMB meeting July 31st. It details the need for FDA regulations. As these meetings occur they update materials presented and also attendees.
To read white paper click on USHRT WHITE PAPER in first link
https://www.reginfo.gov/public/do/viewEO12866Meeting?viewRule=true&rin=0910-ZA76&meetingId=5806&acronym=0910-HHS/FDA
To view all the industry heavyweights participating in videoconferencing
at second meeting.
https://www.reginfo.gov/public/do/viewEO12866Meeting?viewRule=true&rin=0910-ZA76&meetingId=5807&acronym=0910-HHS/FDA
Just noticed that Happy Lane is produced from Kentucky grown hemp.(under the American flag) That is a first.
https://www.thisishealthtransformed.com/happylane
Last weeks PR noted 5700 retail stores. Todays noted 6300 retail stores.
The store locator on the pluscbd website is showing about 100% growth within a 15 mile radius of my zip code in san diego the last three months. They have added a lot of chiropractors and what seems like just individual residences. Not sure
if it will add to the bottom line this Q.
Anyone else been paying attention to the store locator?
https://www.pluscbdoil.com/stores
Not sure if anyone posted this yet but there is a new pluscbd trademark specifically for pets.
Word Mark +PLUSCBD
Goods and Services IC 005. US 006 018 044 046 051 052. G & S: Nutritional supplements for pets; dietary supplements for pets; supplements for pets
Standard Characters Claimed
Mark Drawing Code (4) STANDARD CHARACTER MARK
Serial Number 90072389
Filing Date July 24, 2020
Current Basis 1B
Original Filing Basis 1B
Owner (APPLICANT) CV Sciences, Inc. CORPORATION DELAWARE 10070 Barnes Canyon Road, Suite 100 San Diego CALIFORNIA 92121
Attorney of Record Rosie H. Kim
Type of Mark TRADEMARK
Register PRINCIPAL
Live/Dead Indicator LIVE
Two OMB meetings scheduled this week.
https://www.reginfo.gov/public/do/eom12866SearchResults?pubId=&rin=0910-ZA76&viewRule=true
The new patent application has been published .CVSI submitted this immediately after the patent in May was granted. Looks like higher doses and more delivery methods.(tablets, pills, nasal, transdermally)
United States Patent Application 20200230077
Kind Code A1
Williams; Jonnie R. July 23, 2020
Pharmaceutical Formulations Containing Cannabidiol and Nicotine for Treating Smokeless Tobacco Addiction
Abstract
In one aspect, a method of treating smokeless tobacco addiction comprising administering to an individual in need thereof a pharmaceutical composition comprising nicotine, a therapeutically effective amount of cannabidiol, and a pharmaceutically acceptable vehicle therefor. In some aspects, the composition is administered transmucosally, such as in an oral dosage form or nasal spray. In other aspects, the composition is administered transdermally. In another aspect, a chewable gum contains nicotine in at least a base portion and cannabidiol in at least an outer portion thereof
internet traffic and engagement over the past 90 days seems to be up 20%
over 90 days ago according to the graph. Amazon should be pretty good at this stuff.Not sure why
people are posting sites that show poor visitation unless they have a agenda.
https://www.alexa.com/siteinfo/pluscbdoil.com
Pretty confident that CVSI has registered these domains.
newharvestcbd.com
newharvestcbd.net
newharvestcbd.org
newharvesthemp.com
newharvesthemp.net
newharvesthemp.org
Unknown if its the CBD guidance you reference.
"Details about the document—titled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research”—are sparse. But an FDA spokesperson indicated to Marijuana Moment that it’s related to the agency’s ongoing work to develop broader CBD regulations that could eventually allow for the marketing of cannabis products as dietary supplements or food items."
https://www.marijuanamoment.net/the-white-house-is-reviewing-cbd-and-marijuana-research-guidance-from-fda/
The headline states the OMB review is complete (June 2). Awaiting publishing?
https://insidehealthpolicy.com/daily-news/omb-completes-review-fda%E2%80%99s-cannabis-research-draft-guide
Not much new but here is FDA report to congress on Labeling and adulteration.
https://hempsupporter.com/assets/uploads/CBD-Marketplace-Sampling_RTC_FY20_Final.pdf
They should PR the CV Autoship subscription service with 20% off, free shipping and 50% off every sixth order. Great way to reward loyal customers.
https://view.pluscbd.com/?qs=5a5cb16c707ac2f4e062a114f4d61ce3b7d436a31c0dbdb8fc02cdcbd7820ae1c7118730c44e8feb66ff453f59a0073f19e8b7b325d49656090f503db35d31e0a5c04f46c85c30a1
A update on the clinical trial of pluscbd for arthritic dogs
being conducted by Murray State University (Kentucky). I inquired if the
second round of clinical trials in Feb-March were
able to be completed or needed to be delayed due to covid.
Their response:
"Fortunately we were able to finish the second round of clinical trials. I am working on all of the post clinical trial work this summer and plan to write (and hopefully seek publication) in the Fall 2020 semester."